Inceler Medical Shines At The 46th European Society Of Lymphology Congress

As a pioneer in medical and healthcare innovations, İnceler Medical achieved significant success at the 46th European Society of Lymphology (ESL) Congress. The company's presentation, titled "Multifaceted Treatment of Lipedema: A Case Series," highlighted the latest developments in lipedema treatment and the effectiveness of the Modus ESWT device developed by İnceler Medical. This valuable work offered new approaches and solutions for lipedema treatment, making a notable impact in the field.

The presentation was led by Professor Dr. Suat Doğancı and Physiotherapist Hatice Durmuş. Under their guidance, the research team detailed how the Modus ESWT device has revolutionized lipedema treatment. The device's potential to improve outcomes for patients with lipedema attracted significant attention from congress participants.

This successful presentation earned the İnceler Medical team two prestigious awards at the congress. In addition to Professor Dr. Suat Doğancı and Physiotherapist Hatice Durmuş, the entire research team involved in the project was recognized. These awards are considered a significant achievement, reinforcing İnceler Medical's commitment to innovation and excellence in the industry.

Speaking on behalf of İnceler Medical, Professor Dr. Suat Doğancı stated, "These awards are a recognition of our team's hard work and our innovative approaches in research. We are honored to showcase the success of our Modus ESWT device in treating lipedema on an international platform."

İnceler Medical remains dedicated to advancing its knowledge and expertise in health technologies and developing treatments that offer hope to patients. The company aims to solidify its leadership in the field by participating in such important scientific events and providing innovative solutions to global health challenges.